Cargando…
Pharmacogenomic considerations for repurposing of dexamethasone as a potential drug against SARS-CoV-2 infection
Immunomodulatory and analgesic effects of dexamethasone are clinically well established, and this synthetic corticosteroid acts as an agonist of glucocorticoid receptors. Early results of the RECOVERY Trial from the United Kingdom and others suggest certain benefits of dexamethasone against COVID-19...
Autores principales: | Vohra, Manik, Sharma, Anu Radha, Satyamoorthy, Kapaettu, Rai, Padmalatha S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186476/ https://www.ncbi.nlm.nih.gov/pubmed/34086487 http://dx.doi.org/10.2217/pme-2020-0183 |
Ejemplares similares
-
Pharmacogenomics deliberations of 2-deoxy-d-glucose in the treatment of COVID-19 disease: an in silico approach
por: Prabhu, Navya B., et al.
Publicado: (2022) -
Development of DNA markers using next-generation sequencing approach for molecular authentication of Boerhavia diffusa L. and Tinospora cordifolia (Willd.) Miers
por: Sharma, Anu Radha, et al.
Publicado: (2023) -
Effect of licorice on patients with HSD11B1 gene polymorphisms- a pilot study
por: Devang, Nayana, et al.
Publicado: (2021) -
In vitro bioproduction and enhancement of moscatilin from a threatened tropical epiphytic orchid, Dendrobium ovatum (Willd.) Kraenzl
por: Pujari, Ipsita, et al.
Publicado: (2021) -
Impact of KCNJ11, TCF7L2, SLC30A8, IGF2BP2, PPARG, SLC47A1, STK11, HHEX, KCNQ1, CDKAL1, FTO, CYP2C9, ADIPOQ, CAPN10 gene polymorphisms on risk of type 2 diabetes and therapeutic response to sulfonylurea and metformin therapy
por: Phani, Nagaraja, et al.
Publicado: (2014)